207 related articles for article (PubMed ID: 17148965)
1. Potent knock down of HIV-1 replication by targeting HIV-1 Tat/Rev RNA sequences synergistically with catalytic RNA and DNA.
Sood V; Unwalla H; Gupta N; Chakraborti S; Banerjea AC
AIDS; 2007 Jan; 21(1):31-40. PubMed ID: 17148965
[TBL] [Abstract][Full Text] [Related]
2. Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme.
Unwalla H; Chakraborti S; Sood V; Gupta N; Banerjea AC
Antiviral Res; 2006 Nov; 72(2):134-44. PubMed ID: 16790281
[TBL] [Abstract][Full Text] [Related]
3. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
[TBL] [Abstract][Full Text] [Related]
4. In vitro-selected RNA cleaving DNA enzymes from a combinatorial library are potent inhibitors of HIV-1 gene expression.
Sriram B; Banerjea AC
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):667-73. PubMed ID: 11104672
[TBL] [Abstract][Full Text] [Related]
5. Identification of cleavage sites in the HIV-1 TAR RNA by 10-23 and 8-17 catalytic motif containing DNA enzymes.
Chakraborti S; Banerjea AC
Biomacromolecules; 2003; 4(3):568-71. PubMed ID: 12741771
[TBL] [Abstract][Full Text] [Related]
6. Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy.
Duan L; Zhu M; Ozaki I; Zhang H; Wei DL; Pomerantz RJ
Gene Ther; 1997 Jun; 4(6):533-43. PubMed ID: 9231069
[TBL] [Abstract][Full Text] [Related]
7. Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication.
Caputo A; Rossi C; Bozzini R; Betti M; Grossi MP; Barbanti-Brodano G; Balboni PG
Gene Ther; 1997 Apr; 4(4):288-95. PubMed ID: 9176513
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes.
Ramezani A; Ding SF; Joshi S
Gene Ther; 1997 Aug; 4(8):861-7. PubMed ID: 9338016
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HIV-1 by a double transdominant fusion gene.
Aguilar-Cordova E; Chinen J; Donehower LA; Harper JW; Rice AP; Butel JS; Belmont JW
Gene Ther; 1995 May; 2(3):181-6. PubMed ID: 7614248
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes.
Zhou C; Bahner IC; Larson GP; Zaia JA; Rossi JJ; Kohn EB
Gene; 1994 Nov; 149(1):33-9. PubMed ID: 7958986
[TBL] [Abstract][Full Text] [Related]
11. Biological importance and cooperativity of HIV-1 regulatory gene splice acceptors.
Riggs NL; Little SJ; Richman DD; Guatelli JC
Virology; 1994 Jul; 202(1):264-71. PubMed ID: 8009838
[TBL] [Abstract][Full Text] [Related]
12. In vitro selected RNA-cleaving DNA enzymes from combinatorial libraries.
Chakraborti S; Sriram B; Banerjea AC
Methods Mol Biol; 2004; 252():279-90. PubMed ID: 15017057
[TBL] [Abstract][Full Text] [Related]
13. Rapid protection against human immunodeficiency virus type 1 (HIV-1) replication mediated by high efficiency non-retroviral delivery of genes interfering with HIV-1 tat and gag.
Lori F; Lisziewicz J; Smythe J; Cara A; Bunnag TA; Curiel D; Gallo RC
Gene Ther; 1994 Jan; 1(1):27-31. PubMed ID: 7584056
[TBL] [Abstract][Full Text] [Related]
14. Long-term RNase P-mediated inhibition of HIV-1 replication and pathogenesis.
Hnatyszyn H; Spruill G; Young A; Seivright R; Kraus G
Gene Ther; 2001 Dec; 8(24):1863-71. PubMed ID: 11821940
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymes targeted to cleave HIV-1 TAT/Rev RNA.
Unwalla H; Banerjea AC
Biochem J; 2001 Jul; 357(Pt 1):147-55. PubMed ID: 11415445
[TBL] [Abstract][Full Text] [Related]
16. Technology evaluation: HIV ribozyme gene therapy, Gene Shears Pty Ltd.
de Feyter R; Li P
Curr Opin Mol Ther; 2000 Jun; 2(3):332-5. PubMed ID: 11249628
[TBL] [Abstract][Full Text] [Related]
17. siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS.
Akkina R; Banerjea A; Bai J; Anderson J; Li MJ; Rossi J
Anticancer Res; 2003; 23(3A):1997-2005. PubMed ID: 12894572
[TBL] [Abstract][Full Text] [Related]
18. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for human immunodeficiency virus infection in the humanized SCID mouse model.
Touraine JL; Sanhadji K; Sembeil R
Isr Med Assoc J; 2003 Dec; 5(12):863-7. PubMed ID: 14689754
[TBL] [Abstract][Full Text] [Related]
20. [Construction and in vitro antiviral activity of highly effective artificial miRNA targeting to HIV-1 pol].
Cheng T; Zhang T; Zhang Y; Wei L; Xia D; Wang Y; Zhang J; Xia N
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):63-73. PubMed ID: 20353094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
